Friday, March 12, 2021 2:18:52 PM
$BNOW ~ One of the key elements driving the rapid adoption of DiOx+ in the medical industry is its effectiveness in eliminating dangerous pathogens and viruses. They are on track to complete their Form-10 Filing and Audit to go SEC Fully Reporting this month, which will coincide with up-listing to the OTCQB. https://finance.yahoo.com/news/boon-industries-continues-expand-distribution-130000994.html
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
